FDA Approves Simtriyo for Treating ADHD in Children and Adults

THURSDAY, July 30, 2026-- The U.S. Food and Drug Administration has granted approval of Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg.The...